Concurrence of inflammatory bowel disease and multiple sclerosis

Mayo Clinic Proceedings

Volumn 75, Issue 8, 2000, Pages 802-806

  Kimura, Keiko ^a,b,c,d  

^a Department of Internal Medicine ^*  (United States)

^b MAYO CLINIC   (United States)

^c REGIONS HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COLITIS; CROHN DISEASE; DISABILITY; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; POPULATION RISK; ULCERATIVE COLITIS;

EID: 0033901236     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.8.802     Document Type: Article

References (30)

1. Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis [letter]. Lancet. 1982;2:555.
2. Purrmann J, Arendt G, Cleveland S, et al. Association of Crohn's disease and multiple sclerosis: is there a common background? J Clin Gastroenterol. 1992;14:43-46.
3. Kitchin LI, Knobler RL, Friedman LS. Crohn's disease in a patient with multiple sclerosis. J Clin Gastroenterol. 1991;13:331-334.
4. Buccino GP, Corrente G, Visintini D. Crohn's disease and multiple sclerosis: a single case report. Ital J Neurol Sei. 1994; 15:303-306.
5. Agranoff D, Schon F. Are focal white matter lesions in patients with inflammatory bowel disease linked to multiple sclerosis? [letter]. Lancet. 1995;346:190-191.
6. Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease [letter]. N Engl J Med. 1986;314:586.
7. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease [letter]. N Engl J Med. 1989;321:762-763.
8. Gollop JH, Phillips SF, Melton LJ III, Zinsmeister AR. Epidemiologie aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut. 1988;29:49-56.
9. Stonnington CM, Phillips SF, Melton LJ III, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a community. Gut. 1987:28:402-409.
10. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology. 1990;40:780-786.
11. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT. Update on epidemiology of multiple sclerosis. Mayo Clin Proc. I989;64:808817.
12. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
13. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998;! 14:1161-1168.
14. Loftus EV Jr, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Incidence and prevalence of ulcerative colitis in Olmsted County, Minnesota [abstract]. Gastroenterology. 1997; 112(suppl):AI027.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
16. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. I983;33: 1444-1452.
17. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurland L. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology. 1994;44:28-33.
18. Binder V, Both J, Hansen PK, Hendriksen C, Kreiner S, TorpPedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology. 1982:83:563-568.
19. Nordenvall B, Brostrom O, Berglund M, et al. Incidence of ulcerative colitis in Stockholm County 1955-1979. Scand J Gaxtroenterol. 1985;20:783-790.
20. Hammond SR, de Wytt C, Maxwell 1C, et al. The epidemiology of multiple sclerosis in Queensland, Australia. J Neurol Sei. 1987;80: 185-204.
21. Geissler A, Andus T, Roth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet. 1995; 345:897-898.
22. Dejaco C, Fertl E, Prayer D, et al. Symptomatic cerebral microangiopathy preceding initial manifestation of ulcerative colitis. Dig Dis Sei. 1996;41:1807-1810.
23. Kurtzke JF. Epidemiologie contributions to multiple sclerosis: an overview. Neurology. 1980;30:61-79.
24. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographie variation of inflammatory bowel disease within the United States. Gastroenterology. 1991:100:143-149.
25. Noseworthy JH. Clinical trials in multiple sclerosis. Curr Opin Neurol Neurosurg. 1993;6:209-215.
26. Podolosky DK. Inflammatory bowel disease (second of two parts). NEnglJMed. 1991:325:1008-1016.
27. Goodkin DE, Ransohoff RM, Rudick RA. Experimental therapies for multiple sclerosis: current status. Cleve ClinJ Med. 1992;59:63-74.
28. Prosiegel M, Neu I, Mallinger J, et al. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5lipoxygenase inhibition. Ada Neurol Scand. 1989:79:223-226.
29. Prosiegel M, Neu I, Ruhenstroth-Bauer G, et al. Suppression of experimental autoimmune encephalomyelitis by sulfasalazine [letter]. NEnglJMed. 1989:321:545-546.
30. Uitdehaag BM, Polman CH, de Groot CJ, Huitinga I, Dijkstra CD. Failure of sulfasalazine to influence experimental autoimmune encephalomyelitis [letter]. Ada Neurol Scand. 1991 ;84:173-174.